ScholarGate
助手

方法对比

并排查看您选择的方法;存在差异的行会高亮显示。

EORTC QLQ-CX24:宫颈癌生活质量×EORTC QLQ-LC13:肺癌生活质量×
领域肿瘤学肿瘤学
方法族Process / pipelineProcess / pipeline
起源年份20061994
提出者Greimel, E. R., et al. (EORTC Quality of Life Group)Bergman, B., et al. (EORTC Quality of Life Group)
类型Self-report questionnaireSelf-report questionnaire
开创性文献Greimel, E. R., Kuljanic Vlasic, K., Zwahlen, D., Rand, K., Heitz, U., Havsteen, H., et al. (2006). The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24. Acta Oncol, 45(3), 344–351. DOI ↗Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer, 30A(5), 635–642. DOI ↗
别名QLQ-CX24QLQ-LC13
相关55
摘要The EORTC QLQ-CX24 is a 24-item cervical-cancer-specific module designed to complement the EORTC QLQ-C30 core questionnaire. Developed by Greimel et al. in 2006, it measures sexual/vaginal function, body image, lymphedema, neuropathy, and gastrointestinal symptoms specific to cervical cancer and its treatments. It is the standard cervical cancer-specific QoL instrument in international oncology research.The EORTC QLQ-LC13 is a 13-item lung-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire. Developed and validated by Bergman et al. in 1994, it measures lung-specific symptoms (dyspnea, cough, hemoptysis, chest pain) and treatment toxicities (sore mouth, dysphagia). It is the standard lung cancer-specific QoL instrument in European and international trials.
ScholarGate数据集
  1. v1
  2. 2 来源
  3. PUBLISHED
  1. v1
  2. 2 来源
  3. PUBLISHED

前往搜索 下载幻灯片

ScholarGate方法对比: EORTC QLQ-CX24 · EORTC QLQ-LC13. 于 2026-06-19 检索自 https://scholargate.app/zh/compare